Literature DB >> 17070319

Re: North American white mitochondrial haplogroups in prostate and renal cancer.

Jeffrey A Canter, Asha R Kallianpur, Jay H Fowke.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 17070319     DOI： 10.1016/j.juro.2006.07.067

Source DB:  PubMed          Journal:  J Urol        ISSN： 0022-5347            Impact factor:   7.450


× No keyword cloud information.
  10 in total

1.  Inherited mitochondrial DNA variants can affect complement, inflammation and apoptosis pathways: insights into mitochondrial-nuclear interactions.

Authors:  M Cristina Kenney; Marilyn Chwa; Shari R Atilano; Payam Falatoonzadeh; Claudio Ramirez; Deepika Malik; Mohamed Tarek; Javier Cáceres-del-Carpio; Anthony B Nesburn; David S Boyer; Baruch D Kuppermann; Marquis Vawter; S Michal Jazwinski; Michael Miceli; Douglas C Wallace; Nitin Udar
Journal:  Hum Mol Genet       Date:  2014-02-28       Impact factor: 6.150

2.  Increased expression of ApoE and protection from amyloid-beta toxicity in transmitochondrial cybrids with haplogroup K mtDNA.

Authors:  Kunal Thaker; Marilyn Chwa; Shari R Atilano; Pinar Coskun; Javier Cáceres-Del-Carpio; Nitin Udar; David S Boyer; S Michal Jazwinski; Michael V Miceli; Anthony B Nesburn; Baruch D Kuppermann; M Cristina Kenney
Journal:  Neurobiol Dis       Date:  2016-04-22       Impact factor: 5.996

3.  Landscape of Germline and Somatic Mitochondrial DNA Mutations in Pediatric Malignancies.

Authors:  Petr Triska; Kristiyana Kaneva; Daria Merkurjev; Noor Sohail; Marni J Falk; Timothy J Triche; Jaclyn A Biegel; Xiaowu Gai
Journal:  Cancer Res       Date:  2019-02-01       Impact factor: 12.701

4.  Mitochondrial haplogroups and control region polymorphisms are not associated with prostate cancer in Middle European Caucasians.

Authors:  Edith E Mueller; Waltraud Eder; Johannes A Mayr; Bernhard Paulweber; Wolfgang Sperl; Wolfgang Horninger; Helmut Klocker; Barbara Kofler
Journal:  PLoS One       Date:  2009-07-28       Impact factor: 3.240

5.  No association between typical European mitochondrial variation and prostate cancer risk in a Spanish cohort.

Authors:  Laura Fachal; Antonio Gómez-Caamaño; Vanesa Alvarez Iglesias; Alberto Gómez Carballa; Patricia Calvo; Antonio Salas; Ana Vega
Journal:  J Hum Genet       Date:  2014-06-05       Impact factor: 3.172

Review 6.  Mitochondrial DNA, nuclear context, and the risk for carcinogenesis.

Authors:  Brett A Kaufman; Martin Picard; Neal Sondheimer
Journal:  Environ Mol Mutagen       Date:  2018-01-14       Impact factor: 3.216

7.  Mitochondrial DNA haplogroups and susceptibility to prostate cancer in a colombian population.

Authors:  D Cano; C F Gomez; N Ospina; J A Cajigas; H Groot; R E Andrade; M M Torres
Journal:  ISRN Oncol       Date:  2014-01-28

Review 8.  Mitochondrial genome variation and prostate cancer: a review of the mutational landscape and application to clinical management.

Authors:  Anton M F Kalsbeek; Eva K F Chan; Niall M Corcoran; Christopher M Hovens; Vanessa M Hayes
Journal:  Oncotarget       Date:  2017-08-04

9.  Differential modulation of cancer-related genes by mitochondrial DNA haplogroups and the STING DNA sensing system.

Authors:  Kevin Schneider; Marilyn Chwa; Shari R Atilano; Sonali Nashine; Nitin Udar; David S Boyer; S Michal Jazwinski; Michael V Miceli; Anthony B Nesburn; Baruch D Kuppermann; M Cristina Kenney
Journal:  FASEB Bioadv       Date:  2022-08-26

10.  The saga of the many studies wrongly associating mitochondrial DNA with breast cancer.

Authors:  Antonio Salas; Manuel García-Magariños; Ian Logan; Hans-Jürgen Bandelt
Journal:  BMC Cancer       Date:  2014-09-09       Impact factor: 4.430
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.